文献速递胃肠外科围术期管理与 ERAS

抗生素诱导的肠道菌群破坏导致袖状胃切除术代谢疗效不佳

Antibiotic-induced Disruption of Intestinal Microbiota Contributes to Failure of Vertical Sleeve Gastrectomy.
PubMed 文献 · Ann Surg · 2019-01-01

该研究在饮食诱导肥胖小鼠中探讨围术期肠道菌群组成是否影响袖状胃切除术(VSG)结局。小鼠随机接受VSG或假手术,术后第1-4天暴露于选择性抑制革兰阳性菌(非达霉素、链霉素)或革兰阴性菌(头孢曲松)的抗生素。结果显示,无论抗生素特异性如何,所有抗生素治疗均损害VSG的代谢结局,表现为体重下降减弱、皮下脂肪增加和糖稳态受损,机制涉及胆汁酸信号和抗菌肽产生改变。

要点

  • 围术期短期抗生素暴露加剧VSG术后皮下脂肪增加并损害糖稳态。
  • 不同特异性抗生素均损害VSG代谢结局,但机制通路不同。
  • 非达霉素和链霉素显著改变肝脏胆汁酸信号和脂质代谢。

核心结论

  • 围术期短暂抗生素暴露诱导的菌群失调减弱VSG术后的体重下降和代谢改善。
  • 潜在机制包括胆汁酸稳态破坏和肠道抗菌肽产生减少。
  • 肠道菌群是代谢稳态的重要贡献者,也是影响VSG临床结局的潜在可调控靶点。

研究设计与样本

  • 研究为饮食诱导肥胖小鼠的随机对照实验,比较VSG与假手术。
  • 小鼠在术后第1-4天暴露于选择性抑制革兰阳性菌(非达霉素、链霉素)或革兰阴性菌(头孢曲松)的抗生素。
  • 手术前及术后第7天和第28天表征粪便菌群,术后第30-32天进行代谢表征,第35天处死。

主要发现

  • 与假手术小鼠相比,VSG导致体重下降和肠道菌群组成改变。
  • 抗生素暴露导致菌群α多样性持续降低和组成改变。
  • 所有抗生素治疗均损害VSG代谢结局,与抗菌特异性无关。
  • 非达霉素和链霉素显著改变肝脏胆汁酸信号和脂质代谢。
  • 头孢曲松导致关键抗菌肽更大幅度的减少。

临床怎么用

  • 普通外科医生应关注袖状胃切除术围术期抗生素使用对肠道菌群及代谢结局的潜在不利影响。
  • 围术期应审慎评估抗生素暴露的必要性与时机,避免不必要的菌群破坏。
  • 肠道菌群可作为改善减重手术代谢结局的潜在干预靶点。

局限性

  • 研究为小鼠实验,结论外推至人类需谨慎。
  • 抗生素暴露仅限术后第1-4天,其他时程的影响未探讨。
  • 机制涉及胆汁酸信号和抗菌肽,但具体因果通路未完全阐明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to test whether the perioperative composition of intestinal microbiota can contribute to variable outcomes following vertical sleeve gastrectomy (VSG). SUMMARY OF BACKGROUND DATA: Although bariatric surgery is the most effective treatment for obesity, metabolic outcomes are variable. METHODS: Diet-induced obese mice were randomized to VSG or sham surgery, with or without exposure to antibiotics that selectively suppress mainly gram-positive (fidaxomicin, streptomycin) or gram-negative (ceftriaxone) bacteria on postoperative days (POD) 1-4. Fecal microbiota was characterized before surgery and on POD 7 and 28. Mice were metabolically characterized on POD 30-32 and euthanized on POD 35. RESULTS: VSG resulted in weight loss and shifts in the intestinal microbiota composition relative to sham-operated mice. Antibiotic exposure resulted in sustained reductions in alpha (within-sample) diversity of microbiota and shifts in its composition. All antibiotic treatments proved to be detrimental to metabolic VSG outcomes, regardless of antimicrobial specificity of antibiotics. These effects involved functionally distinct pathways. Specifically, fidaxomicin and streptomycin markedly altered hepatic bile acid signaling and lipid metabolism, while ceftriaxone resulted in greater reduction of key antimicrobial peptides. However, VSG mice exposed to antibiotics, regardless of their specificity, had significantly increased subcutaneous adiposity and impaired glucose homeostasis without changes in food intake relative to control VSG mice. CONCLUSION: Dysbiosis induced by brief perioperative antibiotic exposure attenuates weight loss and metabolic improvement following VSG. Potential mechanisms include disruption of bile acid homeostasis and reduction in the production of gut antimicrobial peptides. Results of this study implicate the intestinal microbiota as an important contributor to metabolic homeostasis and a potentially modifiable target influencing clinical outcomes following VSG.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Jahansouz C, Staley C, Kizy S, et al. Antibiotic-induced Disruption of Intestinal Microbiota Contributes to Failure of Vertical Sleeve Gastrectomy. Ann Surg. 2019. PMID: 31082907. doi:10.1097/SLA.0000000000002729

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。